Cargando…

Safety of primaquine given to people with G6PD deficiency: systematic review of prospective studies

BACKGROUND: Haemolysis risk with single dose or short course primaquine was evaluated in glucose-6-phosphate dehydrogenase (G6PD) deficient people. METHODS: Major electronic databases (to August 2016) were searched for single or short course 8-aminoquinolines (8-AQ) in (1) randomized comparisons aga...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uthman, Olalekan A., Graves, Patricia M., Saunders, Rachel, Gelband, Hellen, Richardson, Marty, Garner, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5568268/ https://www.ncbi.nlm.nih.gov/pubmed/28830424 http://dx.doi.org/10.1186/s12936-017-1989-3

Ejemplares similares

Safety of 8-aminoquinolines given to people with G6PD deficiency: protocol for systematic review of prospective studies
por: Uthman, Olalekan A, et al.
Publicado: (2014)

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2015)

Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2014)

Primaquine or other 8‐aminoquinolines for reducing Plasmodium falciparum transmission
por: Graves, Patricia M, et al.
Publicado: (2018)

Modelling primaquine-induced haemolysis in G6PD deficiency
por: Watson, James, et al.
Publicado: (2017)

Primaquine-induced haemolysis in females heterozygous for G6PD deficiency
por: Chu, Cindy S., et al.
Publicado: (2018)

G6PD deficiency, primaquine treatment, and risk of haemolysis in malaria-infected patients
por: Avalos, Sara, et al.
Publicado: (2018)

Review of the interactions between G6PD deficiency and primaquine therapy for malaria control and elimination
por: Howes, Rosalind
Publicado: (2014)

Origins and implications of neglect of G6PD deficiency and primaquine toxicity in Plasmodium vivax malaria
por: Baird, Kevin
Publicado: (2015)

Prevalence and distribution of G6PD deficiency: implication for the use of primaquine in malaria treatment in Ethiopia
por: Lo, Eugenia, et al.
Publicado: (2019)

Primaquine at alternative dosing schedules for preventing relapse in people with Plasmodium vivax malaria
por: Milligan, Rachael, et al.
Publicado: (2019)

Safety of Single-Dose Primaquine in G6PD-Deficient and G6PD-Normal Males in Mali Without Malaria: An Open-Label, Phase 1, Dose-Adjustment Trial
por: Chen, Ingrid, et al.
Publicado: (2018)

Barriers to routine G6PD testing prior to treatment with primaquine
por: Ley, Benedikt, et al.
Publicado: (2017)

G6PD Variants and Haemolytic Sensitivity to Primaquine and Other Drugs
por: Bancone, Germana, et al.
Publicado: (2021)

Performance of the CareStart™ G6PD Deficiency Screening Test, a Point-of-Care Diagnostic for Primaquine Therapy Screening
por: Kim, Saorin, et al.
Publicado: (2011)

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2021)

Rationale for recommending a lower dose of primaquine as a Plasmodium falciparum gametocytocide in populations where G6PD deficiency is common
por: White, Nicholas J, et al.
Publicado: (2012)

G6PD Deficiency at Sumba in Eastern Indonesia Is Prevalent, Diverse and Severe: Implications for Primaquine Therapy against Relapsing Vivax Malaria
por: Satyagraha, Ari Winasti, et al.
Publicado: (2015)

G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2021)

Case Series of Primaquine-Induced Haemolytic Events in Controlled Trials with G6PD Screening
por: Kosasih, Ayleen, et al.
Publicado: (2023)

Single Low Dose Primaquine (0.25mg/kg) Does Not Cause Clinically Significant Haemolysis in G6PD Deficient Subjects
por: Bancone, Germana, et al.
Publicado: (2016)

Correction: G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
por: Han, Kay Thwe, et al.
Publicado: (2023)

Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria
por: Taylor, Walter R. J., et al.
Publicado: (2021)

Primaquine-induced Severe Hemolysis in the Absence of Concomitant Malaria: Effects on G6PD Activity and Renal Function
por: Douglas, Nicholas M., et al.
Publicado: (2023)

Primaquine ineligibility in anti-relapse therapy of Plasmodium vivax malaria: the problem of G6PD deficiency and cytochrome P-450 2D6 polymorphisms
por: Baird, J. Kevin, et al.
Publicado: (2018)

Verbal autopsy: Critical eye on a valuable tool for mortality surveillance
por: Gelband, Hellen
Publicado: (2021)

Association of CYP2C19, CYP2D6 and CYP3A4 Genetic Variants on Primaquine Hemolysis in G6PD-Deficient Patients
por: Macêdo, Marielle M., et al.
Publicado: (2023)

Genetic Variation of G6PD and CYP2D6: Clinical Implications on the Use of Primaquine for Elimination of Plasmodium vivax
por: Stewart, Alexandra G. A., et al.
Publicado: (2021)

Chloroquine Versus Dihydroartemisinin-Piperaquine With Standard High-dose Primaquine Given Either for 7 Days or 14 Days in Plasmodium vivax Malaria
por: Chu, Cindy S, et al.
Publicado: (2019)

Tolerability and safety of weekly primaquine against relapse of Plasmodium vivax in Cambodians with glucose-6-phosphate dehydrogenase deficiency
por: Kheng, Sim, et al.
Publicado: (2015)

Safety of primaquine in infants with Plasmodium vivax malaria in Papua, Indonesia
por: Setyadi, Agus, et al.
Publicado: (2019)

The reality of using primaquine
por: Burgoine, Kathy L, et al.
Publicado: (2010)

Primaquine: the risks and the benefits
por: Ashley, Elizabeth A, et al.
Publicado: (2014)

Antimicrobial resistance surveillance with whole genome sequencing in Africa: It’s (about) time
por: Grundmann, Hajo, et al.
Publicado: (2018)

The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
por: Chu, Cindy S., et al.
Publicado: (2019)

Understanding human genetic factors influencing primaquine safety and efficacy to guide primaquine roll-out in a pre-elimination setting in southern Africa
por: Awandu, Shehu S., et al.
Publicado: (2018)

Manmade earthquake: the hidden health effects of a blockade-induced fuel crisis in Nepal
por: Budhathoki, Shyam Sundar, et al.
Publicado: (2016)

A trend analysis and sub-regional distribution in number of people living with HIV and dying with TB in Africa, 1991 to 2006
por: Uthman, Olalekan A, et al.
Publicado: (2009)

G6PD Deficiency: A Possible Cardiovascular Risk Factor in Older People
por: Arai, Yasumichi
Publicado: (2021)

Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens
por: Chu, Cindy S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_8rkt7tmgfg0l118tur5eg2t38v